comparemela.com

Medefil Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Medefil Announces Availability of FDA-Approved Emergency Syringes, Atropine Sulfate Injection, USP,

GLENDALE HEIGHTS, Ill. (BUSINESS WIRE) Medefil, Inc., a domestic manufacturer of injectable products, has announced availability of its FDA-approved ANDA products, Atropine Sulfate Injection, USP, 1 mg per 10 mL (0.1 mg/mL), and 10% Calcium Chloride Injection, USP, 1000 mg per 10 mL (100 mg/mL). Both are offered i.

Global Fill Finish Manufacturing Market Outlook Report

Global Fill Finish Manufacturing Markets Outlook 2021-2022 & 2031 - ResearchAndMarkets com

DUBLIN (BUSINESS WIRE) The "Global Fill Finish Manufacturing Market Outlook 2021-2031" report has been added to ResearchAndMarkets.com's offering.The global fill finish manufacturing market is estimated to garner a revenue of near to USD 15830 Million by the end of 2031, up from a revenue of more than USD 5760 Mil.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.